Vascular endothelial growth factor (VECF) is a 45kDa secreted peptide that has potent mitogenic activity specific for endothelial cells in vitro and the ability to induce a strong angiogenic response in vivo. In the present study, 24 h treatment with VEGF resulted in a stimulation of expression of t
Interleukin-1 induces the expression of vascular endothelial growth factor in human pericardial mesothelial cells
β Scribed by Masaharu Hatakeyama; Tadaatsu Imaizumi; Hirotaka Sakaki; Hidemi Yoshida; Hiroshi Tanaka; Hiroto Kimura; Ikuo Fukuda; Kei Satoh
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 357 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0910-8327
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Tumor expansion is dependent on angiogenesis, which is regulated by peptide growth factors of which vascular endothelial growth factor (VEGF) is one of the most selective and potent. VEGF expression is regulated by steroid hormones in a number of systems, including T47-D human breast cancer cells in
## Abstract Vascular endothelial growth factor (VEGF) is a major agent in choroidal and retinal neovascularization, events associated with ageβrelated macular degeneration (AMD) and diabetic retinopathy. Retinal pigment epithelium (RPE), strategically located between retina and choroid, plays a cri
The fibroblast growth factor (FGF) receptor of human umbilical vein-derived endothelial (HUE) cells has been identified by affinity labeling. It has an apparent molecular weight of 130,000. It binds both basic and acidic FGF, but not with epidermal growth factor, insulin, or transferrin. The lectin